McMaster and Local Hospitals Personalize Cancer Treatment

Hot Topics

Favicon Logo

Hamilton Business Review

July 31, 2025
Hand holding blood samples in a lab.

“‘The Juravinski Research Institute (JRI) is supporting a groundbreaking project by Hamilton Health Sciences, McMaster University and St. Joseph’s Healthcare Hamilton that could transform cancer treatment in Hamilton and serve as a model for cancer care across Canada. 

The initiative — called Enhancing Liquid Biopsy Evaluation and Data Analytics for Personalized Medicine or ELEVATe-PM — will develop better ways to detect and track cancer using simple blood tests.

These tests, known as liquid biopsies, can identify minimal residual disease — tiny amounts of cancer that may remain after treatment — and help doctors tailor care to each patient’s needs. 

Led by Aly-Khan Lalani, Tobias Berg and Darryl Leong, the research team brings together clinicians, scientists and digital health experts from Hamilton Health Sciences, McMaster University and St. Joseph’s Healthcare Hamilton.

Patient representatives are also part of the team, ensuring the work reflects real-world needs and experiences. 

‘We’re excited about what this means for cancer patients,” said Lehana Thabane, chair of the JRI scientific committee and vice-president of research at St. Joseph’s Healthcare Hamilton.

‘This project combines cutting-edge diagnostics with artificial intelligence to support more personalized, effective care.’

See what's possible. Bring your discovery to market.

Let Invest Hamilton support you on your path to commercialization.

Name(Required)
Email(Required)

Related Articles

Related

Ready for Launch

Launchit Ventures is going public – and thinks others should, too.   Jamie Harsevoort is a busy, busy man. The CEO of Hamilton-based Launchit Ventures is in the process of taking his company public on the TSX Venture Exchange, in addition to doing his regular day...

read more